Genflow Biosciences plc (LON:GENF)

London flag London · Delayed Price · Currency is GBP · Price in GBX
2.000
+0.150 (8.11%)
Feb 21, 2025, 4:19 PM BST
37.93%
Market Cap 6.64M
Revenue (ttm) 598.04K
Net Income (ttm) -1.53M
Shares Out 349.71M
EPS (ttm) -0.01
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 1,202,948
Average Volume 639,505
Open 1.970
Previous Close 1.850
Day's Range 1.815 - 2.000
52-Week Range 1.323 - 3.406
Beta 2.35
RSI 46.81
Earnings Date Apr 29, 2025

About Genflow Biosciences

Genflow Biosciences plc, together with its subsidiaries, operates as a biotechnology company that focuses on developing biological interventions aimed at tackling the effects of ageing, slowing, and halting the ageing process, and reducing the incidence of age-related diseases with increase in health span in the United Kingdom and Belgium. Its lead compound is GF-1002, a suspension of an adeno-associated viral vector-based gene therapy for intravenous infusion. The company is also developing GF-3001, a topical delivery of SIRT6 to the skin; and... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2021
Employees 5
Stock Exchange London Stock Exchange
Ticker Symbol GENF
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.